Clinical Trials Directory

Trials / Unknown

UnknownNCT06271473

Effect of PPV+ILM Peeling +/- Subretinal Injection of Ringer Lactate in Management of Nontractional Refractory DME

Comparative Study Between Pars Plana Vitrectomy With Internal Limiting Membrane Peeling With or Without Planned Foveal Detachment for Management of Non-tractional Refractory Diabetic Macular Edema

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

To evaluate the efficacy and safety of combined pars plana vitrectomy and planned foveal detachment through subretinal injection of ringer's solution in patients with non-tractional refractory diabetic macular edema.

Detailed description

In non-tractional cases, PPV allows a more efficient clearance of VEGF and other cytokines from the retina and improves retinal oxygenation by promotion of intraocular fluid currents, and relief of any subclinical tractional forces, thereby reducing DME. To evaluate the efficacy and safety of combined pars plana vitrectomy and planned foveal detachment through subretinal injection of ringer's solution in patients with non-tractional refractory diabetic macular edema.

Conditions

Interventions

TypeNameDescription
PROCEDUREvitrectomy + ILM peeling +/- planned foveal detachment via subretinal injection of ringer's solution.vitrectomy + ILM peeling +/- planned foveal detachment via subretinal injection of ringer's solution.

Timeline

Start date
2023-08-30
Primary completion
2024-12-30
Completion
2025-06-30
First posted
2024-02-21
Last updated
2024-08-06

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06271473. Inclusion in this directory is not an endorsement.